<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>Pharmaceutical Litigation Risk Outlook | Hyve Intelligence</title>
<link href="https://fonts.googleapis.com/css2?family=Poppins:ital,wght@0,300;0,400;0,500;0,600;0,700;0,800;1,600;1,700;1,800&display=swap" rel="stylesheet">
<style>
:root {
    --burgundy: #87284B;
    --burgundy-dark: #6b1f3c;
    --burgundy-deep: #A00037;
    --salmon: #FFB9A0;
    --salmon-light: #ffd4c4;
    --peach: #FEEFE0;
    --peach-mid: #FDE4D0;
    --blush: #E3ACBB;
    --dark: #222222;
    --ink: #333333;
    --ink-mid: #5a5a5a;
    --ink-light: #888888;
    --grey-bg: #f9f6f4;
    --grey-light: #e8e4e0;
    --grey-mid: #999;
    --white: #ffffff;
    --green: #2e7d52;
    --green-light: #eef7f0;
    --red-alert: #c44040;
}

* { margin: 0; padding: 0; box-sizing: border-box; }

body {
    font-family: 'Poppins', 'Segoe UI', Arial, sans-serif;
    color: var(--ink);
    background: var(--white);
    -webkit-font-smoothing: antialiased;
    font-size: 15px;
    line-height: 1.7;
}

/* ─── TOP BAR ─── */
.top-bar {
    background: var(--white);
    border-bottom: 1px solid var(--grey-light);
    padding: 0.8rem 2.5rem;
    display: flex;
    align-items: center;
    justify-content: space-between;
    position: sticky;
    top: 0;
    z-index: 100;
}
.top-bar-logo {
    display: flex;
    align-items: center;
    gap: 0.7rem;
}
.top-bar-hex {
    width: 38px; height: 38px;
    background: var(--burgundy-deep);
    clip-path: polygon(50% 0%, 93% 25%, 93% 75%, 50% 100%, 7% 75%, 7% 25%);
    display: flex; align-items: center; justify-content: center;
    flex-shrink: 0;
}
.top-bar-hex span {
    font-size: 0.7rem;
    font-weight: 700;
    font-style: italic;
    color: var(--white);
    margin-top: 1px;
}
.top-bar-brand {
    font-weight: 700;
    font-style: italic;
    font-size: 1.2rem;
    color: var(--burgundy);
    letter-spacing: 0.01em;
}
.top-bar-brand-sub {
    font-weight: 500;
    font-style: normal;
    font-size: 0.65rem;
    color: var(--ink-light);
    letter-spacing: 0.1em;
    text-transform: uppercase;
    margin-top: -0.1rem;
}
.top-bar-right {
    font-size: 0.65rem;
    color: var(--ink-light);
    letter-spacing: 0.08em;
    text-transform: uppercase;
    font-weight: 600;
    background: var(--peach);
    padding: 0.35rem 1rem;
    border-radius: 20px;
}

/* ─── HERO ─── */
.hero {
    position: relative;
    width: 100%;
    min-height: 500px;
    background: #3a1525;
    overflow: hidden;
    display: flex;
    align-items: center;
}
.hero-bg {
    position: absolute; top: 0; left: 0; right: 0; bottom: 0;
}
.hero-bg img {
    width: 100%; height: 100%;
    object-fit: cover; object-position: center;
    opacity: 0.35;
}
.hero-overlay {
    position: absolute; top: 0; left: 0; right: 0; bottom: 0;
    background: linear-gradient(to right, rgba(58,21,37,0.88) 0%, rgba(58,21,37,0.6) 55%, rgba(58,21,37,0.35) 100%);
}
.hero-content {
    position: relative; z-index: 2;
    max-width: 620px;
    margin: 3.5rem 0 3.5rem 5%;
    padding: 0;
}
.hero-content .label {
    font-size: 0.62rem; font-weight: 600;
    letter-spacing: 0.14em; text-transform: uppercase;
    color: var(--salmon);
    margin-bottom: 1rem;
    background: rgba(255,185,160,0.15);
    display: inline-block;
    padding: 0.3rem 0.8rem;
    border-radius: 20px;
}
.hero-content h1 {
    font-size: 2.6rem; font-weight: 800;
    font-style: italic;
    line-height: 1.15; color: var(--white);
    margin-bottom: 1rem;
    letter-spacing: -0.02em;
}
.hero-content .subtitle {
    font-size: 0.92rem; color: rgba(255,255,255,0.7);
    line-height: 1.7; margin-bottom: 1.5rem;
    font-weight: 400;
}
.hero-content .meta-row {
    display: flex; gap: 1.5rem; flex-wrap: wrap;
    padding-top: 1rem;
    border-top: 2px solid rgba(255,185,160,0.3);
}
.hero-content .meta-item {
    font-size: 0.65rem; color: rgba(255,255,255,0.45);
    text-transform: uppercase; letter-spacing: 0.06em;
    font-weight: 500;
}
.hero-content .meta-item strong {
    color: var(--white); font-weight: 700;
    display: block; font-size: 0.78rem;
    margin-bottom: 0.1rem;
}

/* ─── STAT BAND ─── */
.stat-band {
    background: var(--burgundy);
    padding: 2rem 5%;
    display: grid;
    grid-template-columns: repeat(4, 1fr);
    gap: 2rem;
}
.stat-band-item {
    text-align: center;
    color: var(--white);
}
.stat-band-num {
    font-size: 2.5rem;
    font-weight: 800;
    font-style: italic;
    line-height: 1;
    margin-bottom: 0.2rem;
}
.stat-band-label {
    font-size: 0.65rem;
    font-weight: 500;
    letter-spacing: 0.08em;
    text-transform: uppercase;
    opacity: 0.75;
}

/* ─── EDITORIAL ─── */
.editorial {
    max-width: 820px;
    margin: 0 auto;
    padding: 3.5rem 2rem;
}
.editorial-wide {
    max-width: 1080px;
    margin: 0 auto;
    padding: 3.5rem 2rem;
}
.statement {
    font-size: 1.15rem;
    font-weight: 700;
    font-style: italic;
    line-height: 1.6;
    color: var(--burgundy);
    margin-bottom: 1.2rem;
}
.body-text {
    font-size: 0.92rem;
    line-height: 1.85;
    color: var(--ink-mid);
    margin-bottom: 1.2rem;
}
.body-text strong { color: var(--ink); }

/* ─── PULL QUOTE BAND ─── */
.quote-band {
    background: var(--peach);
    color: var(--burgundy);
    padding: 3.5rem 5%;
    text-align: center;
    position: relative;
}
.quote-band::before,
.quote-band::after {
    content: '';
    position: absolute;
    left: 0; right: 0;
    height: 3px;
    background: linear-gradient(to right, var(--salmon), var(--burgundy), var(--salmon));
}
.quote-band::before { top: 0; }
.quote-band::after { bottom: 0; }
.quote-band p {
    font-size: clamp(1.2rem, 2.5vw, 1.65rem);
    font-weight: 700;
    font-style: italic;
    line-height: 1.5;
    max-width: 880px;
    margin: 0 auto;
}
.quote-band p span { color: var(--burgundy-deep); font-weight: 800; }

/* ─── IMAGE BREAK ─── */
.image-break {
    position: relative;
    height: 300px;
    overflow: hidden;
}
.image-break img {
    width: 100%; height: 100%;
    object-fit: cover;
}
.image-break-overlay {
    position: absolute; top: 0; left: 0; right: 0; bottom: 0;
    background: linear-gradient(to bottom, rgba(135,40,75,0.05) 0%, rgba(135,40,75,0.55) 100%);
    display: flex;
    align-items: flex-end;
    padding: 2rem 5%;
}
.image-break-text {
    color: var(--white);
    font-size: 0.68rem;
    font-weight: 600;
    letter-spacing: 0.1em;
    text-transform: uppercase;
}

/* ─── WARM SECTION ─── */
.warm-section {
    background: var(--grey-bg);
    padding: 3.5rem 0;
}

/* ─── SECTION HEADERS ─── */
.section-header {
    margin-bottom: 1.8rem;
}
.section-header .section-label {
    font-size: 0.62rem; font-weight: 600;
    letter-spacing: 0.14em; text-transform: uppercase;
    color: var(--burgundy); margin-bottom: 0.5rem;
    background: rgba(135,40,75,0.08);
    display: inline-block;
    padding: 0.25rem 0.7rem;
    border-radius: 20px;
}
.section-header h2 {
    font-size: clamp(1.4rem, 3vw, 1.8rem);
    font-weight: 800;
    font-style: italic;
    color: var(--burgundy);
    margin-bottom: 0.4rem;
    letter-spacing: -0.01em;
    margin-top: 0.5rem;
}
.section-header p {
    font-size: 0.88rem; color: var(--ink-light);
    max-width: 620px;
}

/* ─── BAR CHART ─── */
.bar-chart { margin: 1.5rem 0; }
.bar-row {
    display: flex; align-items: center;
    margin-bottom: 0.5rem; gap: 0.8rem;
}
.bar-label {
    flex: 0 0 160px; font-size: 0.78rem;
    font-weight: 600; color: var(--dark);
    text-align: right;
}
.bar-track {
    flex: 1; height: 24px;
    background: var(--grey-light);
    border-radius: 12px; overflow: hidden;
    position: relative;
}
.bar-fill {
    height: 100%; border-radius: 12px;
    display: flex; align-items: center;
    padding-left: 0.7rem;
    font-size: 0.7rem; font-weight: 700;
    color: var(--white);
    transition: width 0.6s ease;
}

/* ─── RISK TABLE ─── */
.risk-table {
    width: 100%; border-collapse: collapse;
    margin: 2rem 0;
}
.risk-table thead th {
    text-align: left; padding: 0.7rem 1rem;
    font-size: 0.62rem; font-weight: 600;
    letter-spacing: 0.1em; text-transform: uppercase;
    color: var(--ink-light);
    border-bottom: 2px solid var(--burgundy);
}
.risk-table tbody td {
    padding: 0.8rem 1rem;
    border-bottom: 1px solid var(--grey-light);
    font-size: 0.85rem;
    vertical-align: middle;
}
.risk-table tbody tr:hover {
    background: rgba(135,40,75,0.03);
}
.risk-name { font-weight: 600; color: var(--dark); }
.risk-desc { font-size: 0.72rem; color: var(--ink-light); margin-top: 0.1rem; }
.pct { font-weight: 800; font-style: italic; font-size: 1.05rem; }
.pct-high { color: var(--burgundy); }
.pct-mid { color: #c47a20; }
.pct-low { color: var(--ink-light); }

.dir-badge {
    display: inline-block; padding: 0.18rem 0.6rem;
    border-radius: 12px; font-size: 0.6rem; font-weight: 600;
    letter-spacing: 0.03em; text-transform: uppercase;
}
.dir-rising { background: var(--burgundy); color: var(--white); }
.dir-flat { background: var(--grey-light); color: var(--ink-mid); }
.dir-conflicting { background: #c47a20; color: var(--white); }

.tier-badge {
    display: inline-block; padding: 0.12rem 0.5rem;
    border-radius: 10px; font-size: 0.58rem; font-weight: 600;
    letter-spacing: 0.03em;
}
.tier-1 { background: var(--dark); color: var(--white); }
.tier-2 { background: var(--peach-mid); color: var(--burgundy); }
.tier-3 { background: var(--grey-light); color: var(--ink-light); }

/* ─── GAUGE SVG ─── */
.gauge-row {
    display: grid; grid-template-columns: repeat(3, 1fr);
    gap: 1.5rem; margin: 2rem 0;
}
.gauge-card {
    text-align: center;
    padding: 1.5rem 1rem;
    background: var(--white);
    border: 1px solid var(--grey-light);
    border-radius: 12px;
}
.gauge-svg { width: 150px; height: 85px; margin: 0 auto 0.8rem; display: block; }
.gauge-title {
    font-size: 0.85rem; font-weight: 700;
    font-style: italic;
    margin-bottom: 0.15rem; color: var(--burgundy);
}
.gauge-sub {
    font-size: 0.62rem; color: var(--grey-mid);
    letter-spacing: 0.04em; text-transform: uppercase;
}
.gauge-badges { margin-top: 0.6rem; display: flex; justify-content: center; gap: 0.4rem; }

/* ─── ANALYSIS CARDS ─── */
.analysis-card {
    background: var(--white);
    border: 1px solid var(--grey-light);
    border-radius: 12px;
    margin-bottom: 2rem;
    overflow: hidden;
}
.analysis-card-header {
    padding: 1.5rem 2rem;
    border-bottom: 1px solid var(--grey-light);
    display: flex;
    align-items: center;
    justify-content: space-between;
}
.ac-title {
    font-size: 1.05rem; font-weight: 700;
    font-style: italic;
    color: var(--burgundy);
}
.ac-subtitle {
    font-size: 0.7rem; color: var(--ink-light);
    margin-top: 0.2rem; font-style: normal;
}
.ac-pct {
    font-size: 2.2rem; font-weight: 800;
    font-style: italic;
    line-height: 1;
}
.analysis-card-body {
    padding: 1.5rem 2rem;
}
.analysis-card-body h4 {
    font-size: 0.62rem; font-weight: 600;
    letter-spacing: 0.12em; text-transform: uppercase;
    color: var(--burgundy); margin-bottom: 0.6rem;
    margin-top: 1.2rem;
}
.analysis-card-body h4:first-child { margin-top: 0; }
.prop-table {
    width: 100%; border-collapse: collapse;
    font-size: 0.82rem; margin-bottom: 0.5rem;
}
.prop-table td {
    padding: 0.5rem 0.6rem;
    border-bottom: 1px solid #f0ece8;
    vertical-align: top;
}
.prop-table td:first-child { color: var(--ink-mid); }
.prop-table td:nth-child(2),
.prop-table td:nth-child(3) {
    text-align: center; width: 60px;
    font-weight: 700;
}
.calibration-box {
    background: var(--peach); padding: 1rem 1.2rem;
    border-left: 3px solid var(--burgundy);
    border-radius: 0 8px 8px 0;
    font-size: 0.82rem; color: var(--ink-mid);
    line-height: 1.7; margin-top: 0.8rem;
}

/* ─── SCENARIO ─── */
.scenario-block { margin-bottom: 2.5rem; }
.scenario-block h3 {
    font-size: 1rem; font-weight: 700;
    font-style: italic;
    margin-bottom: 1rem; color: var(--burgundy);
}
.scenario-row {
    display: flex; align-items: center;
    gap: 0.8rem; margin-bottom: 0.5rem;
}
.scenario-text {
    flex: 1; font-size: 0.82rem; color: var(--ink-mid);
    line-height: 1.5;
}
.scenario-text.leading { font-weight: 600; color: var(--ink); }
.scenario-bar {
    width: 120px; height: 6px;
    background: var(--grey-light);
    border-radius: 3px; overflow: hidden;
    flex-shrink: 0;
}
.scenario-bar-fill { height: 100%; border-radius: 3px; }
.scenario-pct {
    font-size: 0.82rem; font-weight: 700;
    font-style: italic;
    min-width: 36px; text-align: right;
}
.scenario-note {
    font-size: 0.72rem; color: var(--grey-mid);
    font-style: italic; margin-top: 0.6rem;
    padding-top: 0.6rem; border-top: 1px solid var(--grey-light);
}

/* ─── TRIGGER CARDS ─── */
.trigger-card { margin-bottom: 2rem; }
.trigger-card h3 {
    font-size: 1rem; font-weight: 700;
    font-style: italic;
    margin-bottom: 0.3rem; color: var(--burgundy);
}
.trigger-card .current {
    font-size: 0.7rem; color: var(--grey-mid);
    margin-bottom: 1rem;
}
.trigger-directions {
    display: grid; grid-template-columns: 1fr 1fr;
    gap: 1.2rem;
}
.trigger-box {
    padding: 1.2rem; font-size: 0.82rem;
    line-height: 1.7; color: var(--ink-mid);
    border-top: 3px solid;
    border-radius: 0 0 10px 10px;
}
.trigger-box.up { background: var(--green-light); border-color: var(--green); }
.trigger-box.down { background: #fef2f2; border-color: var(--red-alert); }
.trigger-box .trigger-label {
    font-size: 0.6rem; font-weight: 600;
    text-transform: uppercase; letter-spacing: 0.1em;
    margin-bottom: 0.4rem;
}
.trigger-box.up .trigger-label { color: var(--green); }
.trigger-box.down .trigger-label { color: var(--red-alert); }

/* ─── METHODOLOGY ─── */
.method-grid {
    display: grid; grid-template-columns: repeat(2, 1fr);
    gap: 1.2rem;
}
.method-item {
    padding: 1.2rem 1.5rem;
    border-left: 3px solid var(--salmon);
    background: var(--white);
    border-radius: 0 10px 10px 0;
}
.method-item dt {
    font-size: 0.62rem; font-weight: 600;
    text-transform: uppercase; letter-spacing: 0.1em;
    color: var(--burgundy); margin-bottom: 0.4rem;
}
.method-item dd {
    font-size: 0.82rem; color: var(--ink-mid);
    line-height: 1.7;
}

/* ─── FOOTER ─── */
.footer {
    background: var(--dark);
    color: rgba(255,255,255,0.5);
    padding: 3rem 2rem;
    text-align: center;
    position: relative;
}
.footer::before {
    content: '';
    position: absolute;
    top: 0; left: 0; right: 0;
    height: 4px;
    background: linear-gradient(to right, var(--salmon), var(--burgundy), var(--salmon));
}
.footer-logo {
    font-weight: 800; font-size: 1.1rem;
    font-style: italic;
    color: var(--white); margin-bottom: 0.5rem;
}
.footer-logo .accent { color: var(--salmon); font-style: normal; font-weight: 500; }
.footer p { font-size: 0.72rem; line-height: 1.8; max-width: 600px; margin: 0 auto; }
.footer .disclaimer {
    font-size: 0.62rem; color: rgba(255,255,255,0.3);
    margin-top: 1rem;
}

/* ─── SUMMARY BAR ─── */
.summary-bar {
    background: var(--burgundy);
    border-radius: 10px;
    padding: 1rem 1.5rem;
    display: flex; gap: 2rem; flex-wrap: wrap;
    margin-top: 1.5rem;
}
.summary-bar div {
    font-size: 0.7rem; color: rgba(255,255,255,0.6);
}
.summary-bar div span {
    color: var(--white); font-weight: 700;
}

/* ─── RESPONSIVE ─── */
@media (max-width: 768px) {
    .stat-band { grid-template-columns: repeat(2, 1fr); }
    .hero-content { margin: 2rem 1rem; max-width: none; }
    .trigger-directions { grid-template-columns: 1fr; }
    .gauge-row { grid-template-columns: 1fr; }
    .method-grid { grid-template-columns: 1fr; }
    .editorial, .editorial-wide { padding: 2.5rem 1.2rem; }
    .bar-label { flex: 0 0 100px; font-size: 0.72rem; }
    .image-break { height: 200px; }
}
@media print {
    .top-bar { position: static; }
}
</style>
</head>
<body>

<!-- ═══ TOP BAR ═══ -->
<header class="top-bar">
    <div class="top-bar-logo">
        <div class="top-bar-hex"><span>Hyve</span></div>
        <div>
            <div class="top-bar-brand">Hyve</div>
            <div class="top-bar-brand-sub">Intelligence</div>
        </div>
    </div>
    <div class="top-bar-right">Risk Intelligence Report</div>
</header>

<!-- ═══ HERO ═══ -->
<section class="hero">
    <div class="hero-bg">
        <img src="hero.png" alt="">
    </div>
    <div class="hero-overlay"></div>
    <div class="hero-content">
        <div class="label">Pharmaceutical Litigation Risk Intelligence</div>
        <h1>Executive Panel Risk Outlook Summary</h1>
        <p class="subtitle">Probability-scored risk assessment across 15 propositions spanning GLP-1 liability, mass-tort signals, litigation funding and regulatory horizon.</p>
        <div class="meta-row">
            <div class="meta-item"><strong>17 Feb 2026</strong> Report date</div>
            <div class="meta-item"><strong>24 hours</strong> Horizon</div>
            <div class="meta-item"><strong>Short-tail</strong> Underwriting</div>
            <div class="meta-item"><strong>15</strong> Propositions</div>
        </div>
    </div>
</section>

<!-- ═══ STAT BAND ═══ -->
<div class="stat-band">
    <div class="stat-band-item">
        <div class="stat-band-num">74%</div>
        <div class="stat-band-label">Highest probability</div>
    </div>
    <div class="stat-band-item">
        <div class="stat-band-num">15</div>
        <div class="stat-band-label">Propositions scored</div>
    </div>
    <div class="stat-band-item">
        <div class="stat-band-num">4</div>
        <div class="stat-band-label">Rising signals</div>
    </div>
    <div class="stat-band-item">
        <div class="stat-band-num">13</div>
        <div class="stat-band-label">Contradiction signals</div>
    </div>
</div>

<!-- ═══ PULL QUOTE ═══ -->
<div class="quote-band">
    <p>Four of 15 risk propositions show rising signals. <span>GLP-1 liability adjacency leads at 74%</span> &mdash; the highest probability score in this assessment cycle.</p>
</div>

<!-- ═══ EDITORIAL INTRO ═══ -->
<div class="editorial">
    <p class="statement">The pharmaceutical litigation landscape is entering a period of accelerated signal convergence. Three risk clusters now command attention.</p>
    <p class="body-text"><strong>GLP-1 liability adjacency</strong> has risen to 74% probability for US federal consolidation within 90 days &mdash; the highest score in this assessment. Compounding channel disputes are driving discovery broadening, and plaintiff intake is scaling through consumer channels.</p>
    <p class="body-text"><strong>Johnson &amp; Johnson mass-tort signals</strong> sit at 61%, with procedural rulings expected to increase settlement pressure. The evidence band remains wide (44&ndash;76%), reflecting live uncertainty around venue-specific developments.</p>
    <p class="body-text"><strong>Third-party litigation funding disclosure</strong> is building momentum at 59%. State-level legislative activity and judicial case-management shifts are combining to push the probability upward.</p>
</div>

<!-- ═══ IMAGE BREAK ═══ -->
<div class="image-break">
    <img src="office.png" alt="">
    <div class="image-break-overlay">
        <div class="image-break-text">Hyve Intelligence &middot; Pharmaceutical Litigation Risk Monitor</div>
    </div>
</div>

<!-- ═══ RISK DASHBOARD ═══ -->
<div class="warm-section">
    <div class="editorial-wide">
        <div class="section-header">
            <div class="section-label">Risk Probability Dashboard</div>
            <h2>Per-Risk Likelihood Matrix</h2>
            <p>All 15 risk propositions ranked by assessed probability. Direction indicates whether the risk is becoming more likely, holding steady, or showing conflicting signals.</p>
        </div>

        <div class="bar-chart">
            <div class="bar-row">
                <div class="bar-label">GLP-1 Adjacency</div>
                <div class="bar-track"><div class="bar-fill" style="width:74%;background:var(--burgundy)">74%</div></div>
            </div>
            <div class="bar-row">
                <div class="bar-label">J&amp;J Mass-Tort</div>
                <div class="bar-track"><div class="bar-fill" style="width:61%;background:#c47a20">61%</div></div>
            </div>
            <div class="bar-row">
                <div class="bar-label">TPLF Disclosure</div>
                <div class="bar-track"><div class="bar-fill" style="width:59%;background:#c47a20">59%</div></div>
            </div>
            <div class="bar-row">
                <div class="bar-label">GLP-1 Injunction</div>
                <div class="bar-track"><div class="bar-fill" style="width:54%;background:var(--salmon)"><span style="color:var(--burgundy)">54%</span></div></div>
            </div>
            <div class="bar-row">
                <div class="bar-label">J&amp;J Venue Shift</div>
                <div class="bar-track"><div class="bar-fill" style="width:46%;background:var(--blush)"><span style="color:var(--burgundy)">46%</span></div></div>
            </div>
            <div class="bar-row">
                <div class="bar-label">TPLF Template</div>
                <div class="bar-track"><div class="bar-fill" style="width:44%;background:var(--blush)"><span style="color:var(--burgundy)">44%</span></div></div>
            </div>
            <div class="bar-row">
                <div class="bar-label">FDA Regulatory</div>
                <div class="bar-track"><div class="bar-fill" style="width:41%;background:var(--grey-light)"><span style="color:var(--ink)">41%</span></div></div>
            </div>
            <div class="bar-row">
                <div class="bar-label">Coverage Drift</div>
                <div class="bar-track"><div class="bar-fill" style="width:39%;background:var(--grey-light)"><span style="color:var(--ink)">39%</span></div></div>
            </div>
            <div class="bar-row">
                <div class="bar-label">Product Safety</div>
                <div class="bar-track"><div class="bar-fill" style="width:37%;background:var(--grey-light)"><span style="color:var(--ink)">37%</span></div></div>
            </div>
            <div class="bar-row">
                <div class="bar-label">Claims AI</div>
                <div class="bar-track"><div class="bar-fill" style="width:34%;background:var(--grey-light)"><span style="color:var(--ink)">34%</span></div></div>
            </div>
            <div class="bar-row">
                <div class="bar-label">Lit. Finance / Re</div>
                <div class="bar-track"><div class="bar-fill" style="width:32%;background:var(--grey-light)"><span style="color:var(--ink-light)">32%</span></div></div>
            </div>
            <div class="bar-row">
                <div class="bar-label">Securities Fraud</div>
                <div class="bar-track"><div class="bar-fill" style="width:31%;background:var(--grey-light)"><span style="color:var(--ink-light)">31%</span></div></div>
            </div>
        </div>

        <table class="risk-table">
            <thead>
                <tr>
                    <th>#</th>
                    <th>Risk Category</th>
                    <th>Probability</th>
                    <th>Direction</th>
                    <th>Band</th>
                    <th>Confidence</th>
                </tr>
            </thead>
            <tbody>
                <tr><td>1</td><td><div class="risk-name">GLP-1 Liability Adjacency</div><div class="risk-desc">US federal consolidation within 90 days</div></td><td><span class="pct pct-high">74%</span></td><td><span class="dir-badge dir-rising">Rising</span></td><td style="font-size:0.75rem;color:var(--ink-light)">63&ndash;83%</td><td><span class="tier-badge tier-1">Tier 1</span></td></tr>
                <tr><td>2</td><td><div class="risk-name">J&amp;J Mass-Tort Signal</div><div class="risk-desc">Material court ruling within 30 days</div></td><td><span class="pct pct-mid">61%</span></td><td><span class="dir-badge dir-rising">Rising</span></td><td style="font-size:0.75rem;color:var(--ink-light)">44&ndash;76%</td><td><span class="tier-badge tier-2">Tier 2</span></td></tr>
                <tr><td>3</td><td><div class="risk-name">TPLF Disclosure Pressure</div><div class="risk-desc">State-level disclosure rule within 90 days</div></td><td><span class="pct pct-mid">59%</span></td><td><span class="dir-badge dir-rising">Rising</span></td><td style="font-size:0.75rem;color:var(--ink-light)">51&ndash;69%</td><td><span class="tier-badge tier-2">Tier 2</span></td></tr>
                <tr><td>4</td><td><div class="risk-name">GLP-1: Court-Ordered Injunction</div><div class="risk-desc">Preliminary injunction on compounded GLP-1</div></td><td><span class="pct pct-mid">54%</span></td><td><span class="dir-badge dir-rising">Rising</span></td><td style="font-size:0.75rem;color:var(--ink-light)">39&ndash;69%</td><td><span class="tier-badge tier-2">Tier 2</span></td></tr>
                <tr><td>5</td><td><div class="risk-name">J&amp;J Venue-Specific Shift</div><div class="risk-desc">Procedural shift increasing claim inventory</div></td><td><span class="pct pct-low">46%</span></td><td><span class="dir-badge dir-flat">Flat</span></td><td style="font-size:0.75rem;color:var(--ink-light)">44&ndash;76%</td><td><span class="tier-badge tier-2">Tier 2</span></td></tr>
                <tr><td>6</td><td><div class="risk-name">TPLF: Standing Order/Template</div><div class="risk-desc">Case-management template requiring disclosure</div></td><td><span class="pct pct-low">44%</span></td><td><span class="dir-badge dir-flat">Flat</span></td><td style="font-size:0.75rem;color:var(--ink-light)">28&ndash;59%</td><td><span class="tier-badge tier-2">Tier 2</span></td></tr>
                <tr><td>7</td><td><div class="risk-name">FDA Regulatory Moves</div><div class="risk-desc">Observable action changing drug risk narratives</div></td><td><span class="pct pct-low">41%</span></td><td><span class="dir-badge dir-flat">Flat</span></td><td style="font-size:0.75rem;color:var(--ink-light)">22&ndash;60%</td><td><span class="tier-badge tier-2">Tier 2</span></td></tr>
                <tr><td>8</td><td><div class="risk-name">Coverage Interpretation Drift</div><div class="risk-desc">Development affecting pharma liability pricing</div></td><td><span class="pct pct-low">39%</span></td><td><span class="dir-badge dir-flat">Flat</span></td><td style="font-size:0.75rem;color:var(--ink-light)">24&ndash;54%</td><td><span class="tier-badge tier-2">Tier 2</span></td></tr>
                <tr><td>9</td><td><div class="risk-name">Product Safety Signals</div><div class="risk-desc">Consumer-safety action within 30 days</div></td><td><span class="pct pct-low">37%</span></td><td><span class="dir-badge dir-flat">Flat</span></td><td style="font-size:0.75rem;color:var(--ink-light)">22&ndash;53%</td><td><span class="tier-badge tier-2">Tier 2</span></td></tr>
                <tr><td>10</td><td><div class="risk-name">Claims Automation Litigation</div><div class="risk-desc">AI-driven claim decision development</div></td><td><span class="pct pct-low">34%</span></td><td><span class="dir-badge dir-flat">Flat</span></td><td style="font-size:0.75rem;color:var(--ink-light)">20&ndash;50%</td><td><span class="tier-badge tier-2">Tier 2</span></td></tr>
                <tr><td>11</td><td><div class="risk-name">Litigation Finance in Reinsurance</div><div class="risk-desc">Funding expands into re/insurance claims</div></td><td><span class="pct pct-low">32%</span></td><td><span class="dir-badge dir-flat">Flat</span></td><td style="font-size:0.75rem;color:var(--ink-light)">17&ndash;49%</td><td><span class="tier-badge tier-3">Tier 3</span></td></tr>
                <tr><td>12</td><td><div class="risk-name">Securities Fraud Filings</div><div class="risk-desc">Securities litigation intersects pharma issuers</div></td><td><span class="pct pct-low">31%</span></td><td><span class="dir-badge dir-flat">Flat</span></td><td style="font-size:0.75rem;color:var(--ink-light)">16&ndash;48%</td><td><span class="tier-badge tier-3">Tier 3</span></td></tr>
                <tr><td>13</td><td><div class="risk-name">Plaintiff Firm Strategy</div><div class="risk-desc">Coordinated filing in non-traditional category</div></td><td><span class="pct pct-low">29%</span></td><td><span class="dir-badge dir-flat">Flat</span></td><td style="font-size:0.75rem;color:var(--ink-light)">14&ndash;46%</td><td><span class="tier-badge tier-3">Tier 3</span></td></tr>
                <tr><td>14</td><td><div class="risk-name">SEC Litigation Chatter</div><div class="risk-desc">SEC enforcement shifts litigation cadence</div></td><td><span class="pct pct-low">27%</span></td><td><span class="dir-badge dir-flat">Flat</span></td><td style="font-size:0.75rem;color:var(--ink-light)">12&ndash;44%</td><td><span class="tier-badge tier-3">Tier 3</span></td></tr>
                <tr><td>15</td><td><div class="risk-name">Single-Domain Suit Burst</div><div class="risk-desc">Legal-notice bursts translate to multi-source signals</div></td><td><span class="pct pct-low">23%</span></td><td><span class="dir-badge dir-conflicting">Conflicting</span></td><td style="font-size:0.75rem;color:var(--ink-light)">10&ndash;45%</td><td><span class="tier-badge tier-3">Tier 3</span></td></tr>
            </tbody>
        </table>

        <div class="gauge-row">
            <div class="gauge-card">
                <svg class="gauge-svg" viewBox="0 0 160 90">
                    <defs><linearGradient id="g1" x1="0%" y1="0%" x2="100%" y2="0%"><stop offset="0%" stop-color="#FFB9A0"/><stop offset="100%" stop-color="#87284B"/></linearGradient></defs>
                    <path d="M 15 80 A 65 65 0 0 1 145 80" fill="none" stroke="#e8e4e0" stroke-width="8" stroke-linecap="round"/>
                    <path d="M 15 80 A 65 65 0 0 1 145 80" fill="none" stroke="url(#g1)" stroke-width="8" stroke-linecap="round" stroke-dasharray="204" stroke-dashoffset="53"/>
                    <text x="80" y="70" text-anchor="middle" font-family="Poppins, sans-serif" font-size="26" font-weight="800" font-style="italic" fill="#87284B">74%</text>
                    <text x="80" y="87" text-anchor="middle" font-family="Poppins, sans-serif" font-size="9" fill="#999">63 &ndash; 83%</text>
                </svg>
                <div class="gauge-title">GLP-1 Liability</div>
                <div class="gauge-sub">Federal consolidation &middot; 90 days</div>
                <div class="gauge-badges"><span class="dir-badge dir-rising">Rising</span> <span class="tier-badge tier-1">Tier 1</span></div>
            </div>
            <div class="gauge-card">
                <svg class="gauge-svg" viewBox="0 0 160 90">
                    <defs><linearGradient id="g2" x1="0%" y1="0%" x2="100%" y2="0%"><stop offset="0%" stop-color="#c47a20"/><stop offset="100%" stop-color="#c47a20"/></linearGradient></defs>
                    <path d="M 15 80 A 65 65 0 0 1 145 80" fill="none" stroke="#e8e4e0" stroke-width="8" stroke-linecap="round"/>
                    <path d="M 15 80 A 65 65 0 0 1 145 80" fill="none" stroke="url(#g2)" stroke-width="8" stroke-linecap="round" stroke-dasharray="204" stroke-dashoffset="80"/>
                    <text x="80" y="70" text-anchor="middle" font-family="Poppins, sans-serif" font-size="26" font-weight="800" font-style="italic" fill="#c47a20">61%</text>
                    <text x="80" y="87" text-anchor="middle" font-family="Poppins, sans-serif" font-size="9" fill="#999">44 &ndash; 76%</text>
                </svg>
                <div class="gauge-title">J&amp;J Mass-Tort</div>
                <div class="gauge-sub">Court ruling &middot; 30 days</div>
                <div class="gauge-badges"><span class="dir-badge dir-rising">Rising</span> <span class="tier-badge tier-2">Tier 2</span></div>
            </div>
            <div class="gauge-card">
                <svg class="gauge-svg" viewBox="0 0 160 90">
                    <defs><linearGradient id="g3" x1="0%" y1="0%" x2="100%" y2="0%"><stop offset="0%" stop-color="#FFB9A0"/><stop offset="100%" stop-color="#c47a20"/></linearGradient></defs>
                    <path d="M 15 80 A 65 65 0 0 1 145 80" fill="none" stroke="#e8e4e0" stroke-width="8" stroke-linecap="round"/>
                    <path d="M 15 80 A 65 65 0 0 1 145 80" fill="none" stroke="url(#g3)" stroke-width="8" stroke-linecap="round" stroke-dasharray="204" stroke-dashoffset="84"/>
                    <text x="80" y="70" text-anchor="middle" font-family="Poppins, sans-serif" font-size="26" font-weight="800" font-style="italic" fill="#c47a20">59%</text>
                    <text x="80" y="87" text-anchor="middle" font-family="Poppins, sans-serif" font-size="9" fill="#999">51 &ndash; 69%</text>
                </svg>
                <div class="gauge-title">TPLF Disclosure</div>
                <div class="gauge-sub">State-level rule &middot; 90 days</div>
                <div class="gauge-badges"><span class="dir-badge dir-rising">Rising</span> <span class="tier-badge tier-2">Tier 2</span></div>
            </div>
        </div>
    </div>
</div>

<!-- ═══ PULL QUOTE 2 ═══ -->
<div class="quote-band">
    <p>The GLP-1 risk cluster is now the single most closely watched proposition in pharmaceutical underwriting. <span>Evidence coherence is high, and the signal is accelerating.</span></p>
</div>

<!-- ═══ RISK ANALYSIS ═══ -->
<div class="editorial-wide" style="padding-top:3.5rem;padding-bottom:1rem;">
    <div class="section-header">
        <div class="section-label">Risk Analysis</div>
        <h2>Top-Tier Risk Assessment</h2>
        <p>Detailed proposition analysis for the highest-probability risk categories, including calibration methodology and evidence quality.</p>
    </div>
</div>

<div class="editorial-wide" style="padding-top:0;">
    <div class="analysis-card" style="border-left: 4px solid var(--burgundy);">
        <div class="analysis-card-header">
            <div><div class="ac-title">GLP-1 Liability Adjacency</div><div class="ac-subtitle">Highest-probability risk &middot; Strong evidence cluster</div></div>
            <div style="display:flex;align-items:center;gap:0.8rem;"><span class="dir-badge dir-rising">Rising</span><span class="tier-badge tier-1">Tier 1</span><span class="ac-pct" style="color:var(--burgundy)">74%</span></div>
        </div>
        <div class="analysis-card-body">
            <h4>Propositions</h4>
            <table class="prop-table">
                <tr><td>US federal consolidation (JPML petition/transfer) within 90 days</td><td><strong>74%</strong></td><td>26%</td><td><span class="dir-badge dir-rising">Rising</span></td></tr>
                <tr><td>Court-ordered preliminary injunction on compounded GLP-1 within 90 days</td><td><strong>54%</strong></td><td>46%</td><td><span class="dir-badge dir-rising">Rising</span></td></tr>
            </table>
            <h4>Calibration</h4>
            <div class="calibration-box"><strong>P1:</strong> High-coherence cluster plus direct mechanism clarification; +13 adjustment from initial 61%<br><strong>P2:</strong> Enforcement-adjacent signal strengthened; +6 adjustment from initial 48%</div>
        </div>
    </div>

    <div class="analysis-card" style="border-left: 4px solid #c47a20;">
        <div class="analysis-card-header">
            <div><div class="ac-title">J&amp;J Mass-Tort Signal</div><div class="ac-subtitle">High-density mass-tort cluster &middot; Moderate evidence</div></div>
            <div style="display:flex;align-items:center;gap:0.8rem;"><span class="dir-badge dir-rising">Rising</span><span class="tier-badge tier-2">Tier 2</span><span class="ac-pct" style="color:#c47a20">61%</span></div>
        </div>
        <div class="analysis-card-body">
            <h4>Propositions</h4>
            <table class="prop-table">
                <tr><td>Material court ruling or procedural order within 30 days</td><td><strong>61%</strong></td><td>39%</td><td><span class="dir-badge dir-rising">Rising (wide)</span></td></tr>
                <tr><td>Venue-specific procedural shift increasing claim inventory within 90 days</td><td><strong>46%</strong></td><td>54%</td><td><span class="dir-badge dir-flat">Flat (wide)</span></td></tr>
            </table>
            <h4>Calibration</h4>
            <div class="calibration-box">High-density mass-tort cluster with recent procedural anchor; widened band under validation silence. Band: 44&ndash;76% (moderate evidence).</div>
        </div>
    </div>

    <div class="analysis-card" style="border-left: 4px solid var(--salmon);">
        <div class="analysis-card-header">
            <div><div class="ac-title">TPLF Disclosure Pressure</div><div class="ac-subtitle">Policy momentum &middot; State-law anchor</div></div>
            <div style="display:flex;align-items:center;gap:0.8rem;"><span class="dir-badge dir-rising">Rising</span><span class="tier-badge tier-2">Tier 2</span><span class="ac-pct" style="color:#c47a20">59%</span></div>
        </div>
        <div class="analysis-card-body">
            <h4>Propositions</h4>
            <table class="prop-table">
                <tr><td>US state-level litigation-funding disclosure rule advancement within 90 days</td><td><strong>59%</strong></td><td>41%</td><td><span class="dir-badge dir-rising">Rising</span></td></tr>
                <tr><td>New standing order/case-management template requiring funding disclosure within 90 days</td><td><strong>44%</strong></td><td>56%</td><td><span class="dir-badge dir-flat">Flat</span></td></tr>
            </table>
            <h4>Calibration</h4>
            <div class="calibration-box">Policy momentum plus state-law anchor; uplift applied. Bands: 51&ndash;69% and 28&ndash;59% respectively.</div>
        </div>
    </div>
</div>

<!-- ═══ SCENARIO OUTLOOK ═══ -->
<div class="warm-section">
    <div class="editorial-wide">
        <div class="section-header">
            <div class="section-label">Scenario Outlook</div>
            <h2>Pathway Distribution Analysis</h2>
            <p>How each top risk might unfold. Scenario weights represent the relative probability of each pathway dominating.</p>
        </div>

        <div class="scenario-block">
            <h3>GLP-1 Liability Adjacency</h3>
            <div class="scenario-row"><span class="scenario-text leading">Compounding channel disputes trigger discovery broadening core theories</span><div class="scenario-bar"><div class="scenario-bar-fill" style="width:35%;background:var(--burgundy)"></div></div><span class="scenario-pct" style="color:var(--burgundy)">35%</span></div>
            <div class="scenario-row"><span class="scenario-text">Plaintiff intake scales via consumer channels before consolidation</span><div class="scenario-bar"><div class="scenario-bar-fill" style="width:34%;background:#c47a20"></div></div><span class="scenario-pct">34%</span></div>
            <div class="scenario-row"><span class="scenario-text">Adverse-event narratives fragment into multiple small suits</span><div class="scenario-bar"><div class="scenario-bar-fill" style="width:20%;background:var(--blush)"></div></div><span class="scenario-pct">20%</span></div>
            <div class="scenario-row"><span class="scenario-text">Regulatory actions narrow marketing and reduce claim scalability</span><div class="scenario-bar"><div class="scenario-bar-fill" style="width:11%;background:var(--grey-light)"></div></div><span class="scenario-pct">11%</span></div>
            <div class="scenario-note">Calibration shift: Compounding-driven discovery pathway increased from 28% (scaffold) to 35%.</div>
        </div>

        <div class="scenario-block">
            <h3>J&amp;J Mass-Tort Signal</h3>
            <div class="scenario-row"><span class="scenario-text leading">Procedural rulings increase settlement pressure and accelerate monetisation</span><div class="scenario-bar"><div class="scenario-bar-fill" style="width:34%;background:var(--burgundy)"></div></div><span class="scenario-pct" style="color:var(--burgundy)">34%</span></div>
            <div class="scenario-row"><span class="scenario-text">Plaintiff advertising/referral networks expand inventory</span><div class="scenario-bar"><div class="scenario-bar-fill" style="width:30%;background:#c47a20"></div></div><span class="scenario-pct">30%</span></div>
            <div class="scenario-row"><span class="scenario-text">Defence causation wins narrow theories and slow intake</span><div class="scenario-bar"><div class="scenario-bar-fill" style="width:20%;background:var(--blush)"></div></div><span class="scenario-pct">20%</span></div>
            <div class="scenario-row"><span class="scenario-text">New product allegations emerge and compete for attention</span><div class="scenario-bar"><div class="scenario-bar-fill" style="width:16%;background:var(--grey-light)"></div></div><span class="scenario-pct">16%</span></div>
            <div class="scenario-note">Calibration status: confirmed; no downstream redistribution trigger.</div>
        </div>

        <div class="scenario-block">
            <h3>TPLF Disclosure Pressure</h3>
            <div class="scenario-row"><span class="scenario-text leading">Disclosure rules tighten, slowing intake but maintaining claim interest</span><div class="scenario-bar"><div class="scenario-bar-fill" style="width:40%;background:var(--burgundy)"></div></div><span class="scenario-pct" style="color:var(--burgundy)">40%</span></div>
            <div class="scenario-row"><span class="scenario-text">Rules remain fragmented; funders adapt via portfolio structures</span><div class="scenario-bar"><div class="scenario-bar-fill" style="width:32%;background:#c47a20"></div></div><span class="scenario-pct">32%</span></div>
            <div class="scenario-row"><span class="scenario-text">Courts resist disclosure; funding becomes stronger amplifier</span><div class="scenario-bar"><div class="scenario-bar-fill" style="width:19%;background:var(--blush)"></div></div><span class="scenario-pct">19%</span></div>
            <div class="scenario-row"><span class="scenario-text">Major adverse compliance event triggers self-regulation</span><div class="scenario-bar"><div class="scenario-bar-fill" style="width:9%;background:var(--grey-light)"></div></div><span class="scenario-pct">9%</span></div>
            <div class="scenario-note">Calibration shift: Tightening-disclosure outcomes increased from 33% (scaffold) to 40%.</div>
        </div>
    </div>
</div>

<!-- ═══ TRIGGERS ═══ -->
<div class="editorial-wide">
    <div class="section-header">
        <div class="section-label">Trigger Analysis</div>
        <h2>What Would Change the Odds</h2>
        <p>Key contradicting evidence and specific developments that would push each top risk higher or lower.</p>
    </div>

    <div class="trigger-card">
        <h3>GLP-1 Liability Adjacency</h3>
        <p class="current">Current estimate: 74% &middot; Rising &middot; Contradicting evidence IDs: 70, 74, 80</p>
        <div class="trigger-directions">
            <div class="trigger-box up"><div class="trigger-label">Upward pressure</div>A visible JPML petition or multiple coordinated federal filings within 14&ndash;30 days would push likelihood toward ~80%+</div>
            <div class="trigger-box down"><div class="trigger-label">Downward pressure</div>Clear regulatory or judicial push channeling discovery away from compounding mechanisms, or early dismissal activity linked to the core mechanism, would materially reduce consolidation probability</div>
        </div>
    </div>

    <div class="trigger-card">
        <h3>J&amp;J Mass-Tort Signal</h3>
        <p class="current">Current estimate: 61% &middot; Rising &middot; Contradicting evidence IDs: 74, 253</p>
        <div class="trigger-directions">
            <div class="trigger-box up"><div class="trigger-label">Upward pressure</div>Court-issued material procedural order (transfer, bellwether scheduling, broad discovery directive) in major venue would push estimate materially higher</div>
            <div class="trigger-box down"><div class="trigger-label">Downward pressure</div>Publicly available indications of discovery constraints or lead plaintiff withdrawal would lower probability</div>
        </div>
    </div>

    <div class="trigger-card">
        <h3>TPLF Disclosure Pressure</h3>
        <p class="current">Current estimate: 59% &middot; Rising &middot; Contradicting evidence IDs: 167, 203</p>
        <div class="trigger-directions">
            <div class="trigger-box up"><div class="trigger-label">Upward pressure</div>New state-law enactment or high-profile administration-led policy statement committing to disclosure timelines would push likelihood materially upward</div>
            <div class="trigger-box down"><div class="trigger-label">Downward pressure</div>Fragmentation of legislative momentum or explicit judicial resistance to funding disclosure would lower near-term probability</div>
        </div>
    </div>
</div>

<!-- ═══ DECISION MATRIX ═══ -->
<div class="warm-section">
    <div class="editorial-wide">
        <div class="section-header">
            <div class="section-label">Decision Matrix</div>
            <h2>Integrated Risk Categories</h2>
            <p>Summarised view mapping internal risk identifiers to likelihood and directional assessment for portfolio-level decisions.</p>
        </div>

        <table class="risk-table">
            <thead><tr><th>Risk ID</th><th>Category</th><th>Likelihood</th><th>Direction</th></tr></thead>
            <tbody>
                <tr><td style="font-weight:700">IR-002</td><td>Mass Tort MDLs</td><td><span class="pct pct-high">74%</span></td><td><span class="dir-badge dir-rising">Rising</span></td></tr>
                <tr><td style="font-weight:700">IR-001</td><td>Litigation Velocity</td><td><span class="pct pct-mid">61%</span></td><td><span class="dir-badge dir-rising">Rising</span></td></tr>
                <tr><td style="font-weight:700">IR-003</td><td>Litigation Finance</td><td><span class="pct pct-mid">59%</span></td><td><span class="dir-badge dir-rising">Rising</span></td></tr>
                <tr><td style="font-weight:700">IR-004</td><td>Regulatory Horizon</td><td><span class="pct pct-low">41%</span></td><td><span class="dir-badge dir-flat">Flat</span></td></tr>
            </tbody>
        </table>

        <div class="summary-bar">
            <div>Propositions scored: <span>15</span></div>
            <div>Scenarios rendered: <span>3</span></div>
            <div>Propositions blocked: <span>3</span></div>
            <div>Contradiction signals: <span>13</span></div>
            <div>Resolution outlook: <span>Present</span></div>
        </div>
    </div>
</div>

<!-- ═══ METHODOLOGY ═══ -->
<div class="editorial-wide" style="padding-bottom:2rem;">
    <div class="section-header">
        <div class="section-label">Methodology</div>
        <h2>Score and Confidence Legend</h2>
        <p>How to interpret the probability scores, direction bands, and confidence tiers used throughout this report.</p>
    </div>
    <div class="method-grid">
        <div class="method-item"><dl><dt>Risk Probability</dt><dd>Assessed likelihood (0&ndash;100%) that a specific outcome will occur within the stated horizon. Higher numbers indicate stronger evidence pointing toward that outcome.</dd></dl></div>
        <div class="method-item"><dl><dt>Scenario Outlook</dt><dd>Distribution across multiple possible pathways. Percentages represent relative likelihood of each pathway dominating; they sum to 100%.</dd></dl></div>
        <div class="method-item"><dl><dt>Direction Band</dt><dd>Whether the risk is becoming more likely (rising), less likely (falling), or flat. Band width shows directional certainty.</dd></dl></div>
        <div class="method-item"><dl><dt>Confidence Tier</dt><dd><strong>Tier 1</strong> = evidence directly addresses the question. <strong>Tier 2</strong> = adjacent evidence requiring inference. <strong>Tier 3</strong> = thin or indirect evidence.</dd></dl></div>
    </div>
</div>

<!-- ═══ FOOTER ═══ -->
<footer class="footer">
    <div class="footer-logo">Hyve <span class="accent">Intelligence</span></div>
    <p>Precision risk analysis for pharmaceutical underwriting &mdash; delivering probability-scored signals to support informed decision making.</p>
    <p class="disclaimer">All predictions are probability-scored analytical signals, not guarantees. Pharmaceutical underwriting (short-tail) &middot; 24-hour horizon &middot; Report generated 17 February 2026</p>
</footer>

</body>
</html>